Sangamo Biosciences Inc. (SGMO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.28+0.10 (+2.39%)
At close: 4:00 PM EDT
People also watch:
SGENALNYPGNXZIOPARRY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open4.20
Prev Close4.18
Bid4.01 x 100
Ask4.30 x 100
Day's Range4.19 - 4.30
52wk Range4.08 - 9.91
1y Target EstN/A
Market Cap302.25M
P/E Ratio (ttm)-4.53
Beta2.71
Volume817,868
Avg Vol (3m)874,971
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube8 days ago

    ETF’s with exposure to Sangamo BioSciences, Inc. : August 19, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Sangamo BioSciences, Inc. Here are 5 ETF’s with the largest exposure to SGMO-US. Comparing the performance and risk of Sangamo BioSciences, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Sangamo BioSciences, Inc. :SGMO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
    Capital Cube16 days ago

    Sangamo BioSciences, Inc. :SGMO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016

    Categories: Yahoo Finance Click here to see latest analysis Sangamo BioSciences, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Sangamo BioSciences, Inc. – Alnylam Pharmaceuticals, Inc, Gilead Sciences, Inc., Amgen Inc., Johnson & Johnson, BioMarin Pharmaceutical Inc., Merck & Co., Inc., Shire PLC Sponsored ADR, ... Read more (Read more...)

  • PR Newswire18 days ago

    Sangamo BioSciences Announces Presentation At The 2016 Wedbush PacGrow Healthcare Conference

    RICHMOND, Calif., Aug. 9, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Sandy Macrae, M.B., Ch.B., Ph.D., Sangamo's president ...